A diagnostic challenge: Life-threatening drug reaction with eosinophilia and systemic symptoms in the setting of a SARS-CoV-2 and human herpesvirus-6 reactivation in a patient with severe hepatic injury on bupropion.

Elkady, Djoni; Okorie, Chiamaka L; Estupiñan, Blanca; Modi, Mitul B; Cotler, Scott J; Lake, Eden

Elkady, Djoni; Okorie, Chiamaka L; Estupiñan, Blanca; Modi, Mitul B; Cotler, Scott J; Lake, Eden.

Afiliação

Elkady D; Loyola University Chicago Stritch School of Medicine, Maywood, Illinois.
Okorie CL; Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire.
Estupiñan B; Division of Dermatology, Loyola University Medical Center, Maywood, Illinois.
Modi MB; Department of Pathology and Laboratory Medicine, Loyola University Medical Center, Maywood, Illinois.
Cotler SJ; Division of Hepatology, Loyola University Medical Center, Maywood, Illinois.
Lake E; Division of Dermatology, Loyola University Medical Center, Maywood, Illinois.

JAAD Case Rep ; 39: 101-105, 2023 Sep.

Article em En | MEDLINE | ID: mdl-37635861

Palavras-chave

COVID; DILI; DRESS; SARS-CoV-2; bupropion; drug reaction; drug-induced; hypersensitivity syndrome

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article